Maternal Hyperoxygenation for Prenatal Risk Stratification of Pulmonary Venous Obstruction in Total Anomalous Pulmonary Venous Return - Report - MDSpire
Clinical Report: Prenatal Risk Assessment of Pulmonary Venous Obstruction in TAPVR
Background
Total anomalous pulmonary venous return (TAPVR) is a rare congenital heart defect that can lead to significant neonatal morbidity and mortality, particularly when pulmonary venous obstruction (PVO) is present. Accurate prenatal identification of PVO is challenging due to low fetal pulmonary blood flow, which can mask obstruction. Advances in fetal echocardiography and maternal hyperoxygenation techniques may improve the detection of PVO.
Data Highlights
Measurement
Baseline
During MHO
Vertical Vein Velocity
Not specified
Increased
RPA PI
Not specified
Reduced by ≥10%
Key Findings
MHO testing can enhance the assessment of PVO risk in fetuses with TAPVR.
Fixed anatomical obstructions may be revealed through disproportionate increases in vertical vein velocities during MHO.
Preserved pulmonary vasoreactivity during MHO indicates a lower risk of severe PVO.
Standard Doppler thresholds for assessing PVO may be limited under baseline fetal conditions.
Initial clinical outcomes in neonates correlated with MHO findings.
Clinical Implications
The use of maternal hyperoxygenation during fetal echocardiography may provide insights into the risk of postnatal pulmonary venous obstruction in TAPVR cases.
Conclusion
Maternal hyperoxygenation may be an approach for evaluating the risk of pulmonary venous obstruction in fetuses diagnosed with TAPVR.